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Background: Risk assessment informs decisions around admission to and discharge 
from secure psychiatric hospital and contributes to treatment and supervision. There are 
advantages to using brief, scalable, free online tools with similar accuracy to instruments 
currently used. We undertook a study of one such risk assessment, the Forensic Psychiatry 
and Violence Oxford (FoVOx) tool, examining its acceptability, feasibility, and practicality.
Methods: We completed the FoVOx tool on all discharges from six secure psychiatric hospitals 
in one region in England over two years. We interviewed 11 senior forensic psychiatrists 
regarding each discharge using a standardized questionnaire. Their patient’s FoVOx score 
was compared to clinical risk assessment, and the senior clinicians were asked if they 
considered FoVOx scores accurate and useful. A modified thematic analysis was conducted, 
and clinicians were surveyed about current risk assessment practice on discharge.
Results: Of 90 consecutive discharges, 84 were included in the final analysis. The 
median FoVOx probability score was 11% risk of violent recidivism in two years after 
discharge. We estimated that 12 (14%) individuals reoffended since discharge; all were 
in the medium or high risk FoVOx categories. Clinical assessment of risk agreed with the 
FoVOx categories in around half the cases. Clinicians were more likely to provide lower 
risk categories compared with FoVOx ones. FoVOx was considered to be an accurate 
representation of risk in 67% of cases; clinicians revised their view on some patient’s risk 
assessment after being informed of their FoVOx scores. Completing FoVOx was reported 
to be helpful in the majority of cases. Reasons included improved communication with 
other agencies, reassurance to clinical teams, and identifying additional factors not fully 
considered. 10 of the 11 respondents reported that FoVOx was practical, and seven of 
11 reported that they would use it in the future, highlighting its brevity and speed of use 
compared to existing risk assessment tools.
Conclusions: Senior clinicians in this regional forensic psychiatric service found the 
FoVOx risk assessment tool feasible, practical, and easy to use. Its use addressed a lack 
of consistency around risk assessment at the point of discharge and, if used routinely, 
could assist in clinical decision-making.
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inTRODUCTiOn
After discharge from forensic psychiatric hospital, rates of violent 
reoffending are reported to range from 2% to 8% per year in high 
income countries, and one cohort study based on around half of 
the forensic hospitals in England reported that 1 in 8 men and 
1 in 16 women were convicted of serious offences over a mean 
follow-up of 6 years (1). Thus, risk assessment has become an 
integral part of forensic mental health in order to inform decisions 
about admission, management, and discharge (2). Further, 
professionals working in forensic mental health regularly advise 
court proceedings, which can involve considerations of future risk.
If accurately done, risk assessment should identify those patients 
presenting with the highest risk, reduce length of stay, and assist 
in treatment allocation. Structured violence risk assessment is 
broadly split into two approaches: actuarial tools, which use 
statistical methods to give a population-based percentage chance 
of reoffending, and structured professional judgment tools, which 
attempt to guide mental health professionals by identifying some 
risk factors. Structured professional judgment tools are more 
frequently used in clinical settings. In the UK, for example, 90% of 
medium secure units report using them in one survey (3), and their 
completion is used as a key performance indicator (4). However, 
there are important problems with using them (5). Structured 
professional judgment tools take a long time to complete, for 
example 15 person-hours to complete an initial HCR-20 (6). They 
often have low to moderate validity in field studies (7), have often 
been developed in prison, rather than hospital, settings, and using 
methods to derive them which are dated. Further, there have been 
low standards in reporting, including few performance measures, 
authorship bias (8), wide variations in what constitutes ‘high’ risk 
(9), and their underlying risk factors are based on heterogeneous 
samples and do not incorporate new evidence on risk (10). In the 
case of the commonly-used HCR-20 and PCL-R, for example, it has 
been found that most of the factors are not predictive (11). One 
new approach has been to use solely dynamic risk factors, but this 
may lead to harsher penalties for minority groups by conflating 
risk with rehabilitative needs (12) and also poor accuracy as strong 
risk factors for reoffending including sex, age, and criminal history 
are omitted. Thus, the potential use of high-quality actuarial tools 
needs reconsideration in forensic mental health (13).
One such tool is the Forensic Violence Oxford (FoVOx) tool 
(14), which was developed using all forensic psychiatric patients 
in Sweden and based on the largest forensic psychiatric sample 
to date. When reported, the FoVOx study was novel in that it 
incorporated independent risk factors tested in a large sample, 
reported calibration (observed vs. expected probabilities) 
and published a study protocol. The FoVOx tool also has the 
advantage of using routinely available data, which are less liable 
to bias than interview-based measures (e.g. of a personality 
trait). The 12 items within the FoVOx tool are sex, age, previous 
violent crime, previous serious violent crime, primary discharge 
diagnosis, drug use disorder at point of hospitalization or 
discharge, any lifetime drug use disorder, alcohol use disorder 
at point of hospitalization or discharge, personality disorder at 
discharge, employment at admission, five or more prior inpatient 
episodes, and whether current length of stay has exceeded one 
year. The FoVOx tool is scalable, quick, free to use and available 
online. All the model coefficients are reported, meeting a key 
concern of using clinical prediction models that they should be 
transparent. In the derivation sample, the AUC was 0.77, which 
makes it as accurate in terms of discrimination as existing tools 
(15). Its use could enable clinicians to provide a reasonably 
accurate risk assessment in a brief and cost-effective way, and 
free up time to focus on clinical care and risk management rather 
than risk assessment. Possible limitations of the FoVOx tool are 
that it does not specifically predict serious (as opposed to any) 
violent reoffending and has not been externally validated to date.
In addition to external validation, prior to introducing any 
new risk assessment into a clinical setting, information about 
potential users and their decision-making is necessary (16). 
Clinical impact should be assessed, including where it could sit 
in the clinical pathway and the consequences of its use. Attitudes 
towards any tool should be sought, and any preconceptions 
about risk prediction models identified. Therefore, we undertook 
a feasibility study of the FoVOx tool, assessing its acceptability 
to professionals, demand for its use, and its practicality in one 
regional English forensic psychiatric service.
MeThODS
The study protocol used a mixed methods approach by identifying 
discharged patients and scoring them using the FoVOx tool at 
the point of their discharge, which was followed up by qualitative 
work assessing clinician views about the use of the FoVOx tool.
Sample
Patients
We identified all consecutive patients discharged from the 
Thames Valley Forensic Mental Health Services between March 
2016 and March 2018, covering three counties (Oxfordshire, 
Buckinghamshire and Berkshire) across different levels of security 
(medium and low security, and a pre-discharge unit). All patients, 
both male and female, were included in the study irrespective of 
diagnosis or any other individual factor. All were over the age 
of 18. If any patients were discharged more than once from the 
service during that time, the most recent discharge was selected.
Clinicians
We interviewed all the senior clinicians (‘Responsible Clinicians’) 
in the service, made up of eight men and three women. In England 
and Wales, Responsible Clinicians are the legally considered 
the lead professionals involved in the care of detained forensic 
mental health patients. All Responsible Clinicians in the service 
were consultant (i.e. certified on the General Medical Council 
Specialist Register) forensic psychiatrists.
Measures
FoVOx
Two members of the study team (AL and OP) accessed the 
electronic healthcare record (‘Care Notes’) of the discharged 
patients to obtain the information required to calculate their 
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FoVOx score at the point of the most recent discharge, using an 
online calculator available at https://oxrisk.com/fovox/.
Questionnaire
A standardized tool was developed to collect views and 
information from senior clinicians (Appendix 1). Each clinician 
underwent an in-depth interview by one of the study team (RC, 
OP, or AL) regarding each discharge. The standardized tool 
contained no patient identifiable information. The anonymized 
discharge number was the only identifier. During the interviews, 
patients’ identities and discharge location were shared in order to 
collect the clinician view on risk assessment of their own patients.
The clinician was asked to provide their estimate of the 2-year 
risk of a violent conviction (meaning any interpersonal violent 
or sexual offence) at the point of their most recent discharge. 
They were asked to provide a high, medium or low risk rating 
in line with pre-specified FoVOx categories): Low (< 5% chance 
of violent offending within two years of discharge), Medium 
(5–20%), High (> 20%) or state if they could not recall this. They 
were then asked if, according to their knowledge, their patient 
had committed a violent offence since that period of discharge.
After this, the patient’s FoVOx score (both probability 
and categorical) at the time of discharge was shared with 
the Responsible Clinician. Cohen’s Kappa was calculated 
for agreement between clinical categorical risk assessment 
and FoVOx category. The clinician was then asked if they 
considered this to be a fair representation of their risk and if 
not, why. Participants were also asked whether it would have 
been of benefit to know the FoVOx probability and categorical 
score at the point of discharge, for example by altering clinical 
management at that point. Reasons were again given for each 
case. Answers to the two questions about whether FoVOx was 
accurate and useful were recorded, using the interviewee’s 
wording and with an opportunity for the clinician interviewed 
to confirm that the transcribed notes represented their stated 
reasons. One researcher (RC) analyzed these records, creating 
individual response codes, noting how often these were each 
stated and thematically grouped them. The transcripts were then 
read by a second researcher (OC), who re-analyzed according to 
themes independently, before the two researchers met to agree a 
consensus about the principal themes.
The clinician was next asked whether they routinely use a risk 
assessment tool at discharge in order to check whether they were 
already using the FoVOx tool and to determine whether they 
were using other tools they consider effective.
The unpopulated FoVOx tool was then shown to the clinician. 
They were asked their views on its practicality, ease of use, and 
future plans for risk assessment. Participants were asked to give 
specific reasons as to whether they thought FoVOx was practical 
to use, and whether they would use FoVOx in the future. Again, 
these responses were recorded and coded and grouped into 
themes by two researchers (RC and OC).
ethics
The project was approved by the Oxford Health NHS Foundation 
Trust Clinical Governance Committee in March 2018 and by 
the Clinical Lead for Forensic Services as a Service Evaluation 
project. Therefore, individual informed consent was not deemed 
necessary. No data beyond that collated in routine clinical care 
was used, and the management of patients was not impacted 
by the study. To identify patients, existing discharge data 
being collected by the Trust for audit purposes was used. All 
Responsible Clinicians participated in the study voluntarily, and 
patient data was anonymized other than for the ‘unblinding’ 
during the Responsible Clinician interviews.
ReSUlTS
Sample
Ninety discharges from forensic psychiatric hospitals were 
identified from May 2016 to May 2018. Six patients were 
excluded from analysis (two had been transferred to another 
secure psychiatric setting, one deported abroad and three were 
aged over 65 years). Thus, 84 patients were included in the study 
(Figure 1). Of these, 11 were female (13%). One transgender 
patient had their assigned gender used for FoVOx scoring (17). 
The mean age of patients was 39.2 years, SD 10.7, range 21–60.
The number of discharged patients per clinician was 2 to 18. The 
median number of days from discharge to study interview was 485 
(interquartile range 339–643). Sample characteristics and FoVOx 
scores are included in Table 1. 9 of the 11 clinicians (82%) reported 
that they routinely completed a risk assessment process around the 
time of discharge. These included a multi-disciplinary clinical risk 
assessment, a description of risk in a Mental Health Review Tribunal 
Report, the patient’s latest HCR-20, and HoNOS (Health of the 
Nation Outcome Scales). One respondent reported regularly using a 
structured risk assessment specifically at the point of discharge.
FoVOx Scores
FoVOx scores were calculated from clinical records and took no 
more than 15 minutes per case. The median FoVOx probability 
score was a 11% chance of violent recidivism in 2 years (interquartile 
range 6–19%, range 2–49%). In terms of categories, 12 (14%) were 
low risk, 55 (66%) medium risk and 17 (20%) high risk. Some 
individual items were missing for 15 patients, and for these a FoVOx 
risk score range was generated (as per the online calculator). Of 
these, four ranges crossed low-medium or medium-high categories. 
In these cases, the higher risk rating was presented to the clinician.
Recidivism
Of the 84 patients included, five were lost to follow up. Of the 
remaining 79 who were still in contact with mental health 
services, 12 (14%) were reported to have committed a violent 
offence since discharge based on information known to the 
Responsible Clinicians. Of these, eight had FoVOx scores in the 
medium category and four were in the high category.
Concordance Between FoVOx Scores and 
Clinical Judgment (Case by Case)
There was agreement for risk assessment based on three categories 
(i.e. low/medium/high) between the clinical unstructured 
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judgment and the FoVOx score in 49% of cases (41 out of 84; 
κ = 0.20 [95% CI, 0.06–0.35]). Where there was disagreement, 
clinicians were more likely to score patients in a lower risk category 
compared with their FoVOx score (in 36 of the 43 cases). When 
considering two risk categories: low and medium/high, there was 
agreement between clinical unstructured judgment and the FoVOx 
score in 63% of cases (53 out of 84; κ = 0.22 [95% CI, 0.06–0.38]). 
For most cases (56 out of 84, 67%), the FoVOx score (combined 
categorical and probability) was felt by the clinician to be an accurate 
representation of the violence risk at discharge. In the 28 cases 
(33%) where it was not, the clinician was asked to give reasons. Two 
main themes were identified. The first was that clinicians viewed 
certain risk factors as dynamic and modifiable by treatment, such as 
substance abuse and the response to medication and psychological 
treatment; “The dynamic risk factors have been modified in hospital, 
there was no alcohol or drug use on discharge and these were relevant 
for previous offending” and “The risk is too high, it doesn’t take into 
account any completed therapeutic intervention.” These were thought 
to contribute to risk in both directions; if the patient had responded 
to treatment the FoVOx score was felt to be an overestimate, and 
vice versa. The second theme was that clinicians felt that there were 
additional factors which influenced risk which were not measured 
by the FoVOx tool. These included the recency of offending and 
violence, and the nature of supervision in the community, as well 
as cases in which the patient was only felt to pose a risk in a specific 
set of circumstances: “Risk is over-represented as there has not been 
any violence for the past 15 years”, “The estimated risk is too high; 
the patient has engaged very well with treatment and supervision in 
the community” and “This tool underestimates risk as relationship 
instability is a risk factor”. These themes are summarized in Table 2.
Views on Utility At the Point of Discharge 
(Case by Case)
Responsible Clinicians reported that it would have been helpful 
to know FoVOx scores at the point of discharge in 49 (58%) cases, 
and not that helpful in 35 (42%) cases. Qualitative feedback is 
summarized in Table 3. The most frequent reasons given for 
why FoVOx would be helpful were related to its concordance 
with existing clinical risk assessment, including supporting and 
providing further evidence of the clinical categorization of risk 
if it aligned with the FoVOx score; “(It) can offer confirmation of 
FigURe 1 | Inclusion of discharged patients from secure hospital into study.
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informal risk assessment”. Improved information sharing with 
other agencies was repeatedly noted, including being used as 
an additional source of evidence; “this was a high-profile case 
and the Tribunal was reluctant to discharge, perhaps the clinical 
view over-estimated risk and it would have been helpful to have 
the FoVOx score”. It was also reported, for 14 cases, that using 
FoVOx would identify risk factors which had not been fully 
considered by clinicians, suggesting that it could impact on 
risk management in addition to risk assessment; “Can confirm 
risk assessment and help identify and consider other risk factors” 
and “Identifies outstanding areas of risk”. In cases where FoVOx 
was considered not useful, the most common reason given was 
clinicians not attributing value to any actuarial tool; “Won’t 
add value to clinical practice and is unlikely to add to discharge 
planning. Doesn’t use any clinical risk factors, such as insight”. 
Other comments included that it might lead to unintended 
consequences. For example, FoVOx could increase anxiety if 
it rated patients at higher risk than clinical assessment. It was 
also reported that sharing the FoVOx score could lead to delays 
in liaison with other agencies, for example if they refused or 
delayed housing or support on discharge on the basis of high 
risk; “Can increase anxiety and delay discharge planning, induce 
self-doubt in clinical decision-making, make other teams reluctant 
to take over care.”
Overall Opinion of Practicality and Future Use
After reviewing individual discharges, 10 (90%) clinicians 
reported that the FoVOx tool is practical to use and that it could 
be completed without reference to medical notes. All respondents 
could complete FoVOx scoring in under 1 minute for their most 
recent discharged patient.
Seven of 11 (64%) respondents reported that they would use 
FoVOx in the future for a number of reasons (Table 4). In addition to 
improved information sharing and possible impact on management, 
there were a range of positive comments about the FoVOx tool 
specifically. These included the ease with which information could 
be found, and the speed with which it could be completed. Criticisms 
included the emphasis on static, historical factors, inability to 
specifically predict serious (as opposed to any) violence, and a 
preference to see validation studies in a UK forensic sample before 
local adoption.
Finally, clinicians were asked if they had any other comments 
regarding the FoVOx tool. Its potential use at an earlier stage, 
either at gatekeeping or to screen referrals, was noted twice. The 
benefits of its brevity and speed of use over existing actuarial 
tools were repeatedly noted, even among clinicians who felt that 
actuarial risk assessment tools were of little value: “If we have to 
use an actuarial tool then I would use this” and “Straightforward, 
reassuring, also helpful/interesting to consider cases where there is 
discrepancy. Nothing to lose, why wouldn’t you?”. Three respondents 
stated that the low/medium/high risk categories were unnecessary. 
There were also some specific queries about individual cases, 
including whether those in full-time education at the time of their 
index offence should be considered as employed, and classifying 
some UK offences as serious or aggravated/otherwise.
DiSCUSSiOn
We examined the use of a novel violence risk assessment tool 
(FoVOx) on 84 consecutive discharges from secure (forensic) 
psychiatric hospitals within one region of England over 2 years 
to assess its feasibility and acceptability. As part of this, individual 
interviews were conducted with senior clinicians regarding each 
discharge to assess the potential impact of the FoVOx tool on risk 
assessment and management.
TABle 2 | Qualitative feedback on challenges with FoVOx scoring.
Theme Sub theme FoVOx score is too high FoVOx score is too low
Dynamic Risk 
Factors
Primary discharge diagnosis—
medical treatment
Good response to medication Poor response to medication
Personality disorder diagnosis—
psychological treatment
Successful (increased insight, specific work on 
offence)
Unsuccessful (non-engagement, untreated 
personality disorder)
Substance misuse diagnosis No longer using substances High risk of substance misuse after discharge
Risk factors not 
identified by 
FoVOx
Supervision Engaged with community mental health support, 
use of statutory supervision
Uncooperative with supervision
Chronicity of violence No violence in hospital Frequent violence in hospital
Psychosocial support Improved relationships with family, good 
psychosocial functioning, lifestyle change
Relationship instability
Specific circumstances to index 
offence
No forensic history prior to index offence, long 
period of time since index offence, offending 
could only occur in a specific context
Lengthy past forensic history, unpredictability
TABle 1 | Sample characteristics and FoVOx scores.
Demographics
Male:female   
Age at discharge (SD)
73:11
39.2 (10.7)
Median days since 
discharge (IQR)
485 (334–643)
Median FoVOx score 
(range)
11% (2%–49%)
FoVOx categories All included patients Violent recidivists (based 
on clinician recall)
-Low 12 (14%) 0
-Medium 55 (66%) 8 (67%)
-High 17 (20%) 4 (33%)
Responsible clinician 
view on FoVOx
Yes No
-Accurate? 56 (67%) 28 (33%)
-Helpful? 49 (58%) 35 (42%)
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We found that the data required to complete the FoVOx tool 
was routinely collected, and there was no need to seek additional 
sources of information other than the patient’s electronic healthcare 
record. Furthermore, in 82% of forensic psychiatric patients 
included in this study, all the information required to complete 
FoVOx could be extracted from the individual’s clinical record by 
a mental health professional unfamiliar with their case within 15 
minutes. When one or more pieces of data were unknown, FoVOx 
generated a range of probability scores. For the lead clinician, 
FoVOx could be completed in around 1 minute for their most 
recent discharge and without recourse to clinical notes. Therefore, 
we conclude that FoVOx is feasible for clinicians familiar with 
a case; it is practical to use, requires no additional training, and 
minimal resource allocation. The brevity of the tool was repeatedly 
considered a strength in the qualitative clinician interviews.
We found a lack of any agreed practice around risk assessment 
at the point of discharge in this sample of UK forensic 
psychiatrists. Although these clinicians reported that they did 
complete a risk assessment, its nature varied. Some used existing 
tools completed within the prior 6 months, others a clinical 
assessment comprising a descriptive account in a psychiatric 
report, and some a multi-disciplinary discussion of risk.
The qualitative part of this investigation found that completing 
FoVOx was helpful to most clinicians. Benefits included improved 
information sharing with other agencies, reassurance for the clinical 
team, and identification of unaddressed or underweighted risk 
factors. FoVOx also assisted in guiding community management 
after discharge. In the future, 7 of the 11 clinicians reported that 
they would use FoVOx as part of their clinical practice. Benefits 
over existing tools used included its brevity, the ease with which 
information can be found, and how it clearly and transparently 
outlined a particular patient’s risk to other agencies who are less likely 
to be familiar with more detailed structured professional judgment 
tools currently used in forensic mental health settings. Clinicians 
who said that they would not use it in future provided mostly 
neutral feedback including that it did not provide any additional 
value. Specific criticisms were not unexpected, including the lack of 
dynamic factors, and the view that clinical risk assessment is more 
accurate than actuarial tools. Some of the themes identified when 
clinicians thought FoVOx was inaccurate may actually be indirectly 
measured by the tool. For example, close supervision was felt to 
reduce risk of recidivism. The FoVOx item regarding stay of over a 
TABle 4 | Qualitative feedback on whether clinicians would use FoVOx in  
the future.
Reasons for using Reasons for not using
FoVOx 
specific
Information is easy to find Based on static, historical 
risk factors
No actuarial tool is of value
Information can be found 
quickly
May narrow thinking about 
risk assessment
Useful adjunct to existing 
risk assessment
Not wishing to add another 
tool to existing metrics
Lack of sensitive clinical risk 
factors (e.g. insight, response 
to medication)
Has construct validity Not yet validated in a UK 
forensic population
Inability to predict serious, as 
opposed to any violence
information 
sharing
Information sharing with 
other agencies
Resolves disagreements 
about risk
impact on 
management
Reassurance when agrees 
with clinical opinion
No added value if agrees with 
existing risk assessment
May provide false 
reassurance
Helpful challenge when 
disagrees with clinical 
opinion
Guides community 
management (e.g. level of 
supervision)
TABle 3 | Qualitative feedback on the usefulness of FoVOx scoring.
Theme Sub Theme helpful Unhelpful
Used as evidence 
to support 
decision-making
As part of discharge planning Other agencies more likely to support 
discharge, e.g. Mental Health Review 
Tribunals, Parole Board
Could lead the same agencies less likely to 
discharge, FoVOx score is less relevant if 
patient is discharged due to circumstances 
other than a reduction in risk
In liaison with third parties Improved information sharing with 
accommodation providers, non-forensic 
mental health services, probation and MAPPA
Negative responses such as not accepting 
patient for housing.
Risk assessment Reassurance Reassurance if agrees with clinical 
assessment, reducing anxiety if FoVOx rates 
risk lower than clinician
No added value if FoVOx and clinician 
assessment agree, increasing anxiety and 
leading to review  if FoVOx rates risk higher 
than clinician
Changing patient management Identification of unaddressed risk factors and 
informing management decisions such as 
threshold to recall
Over or under-estimates risk due to reliance on 
historical factors
Existing perceptions of risk assessment Highlights over-reliance on clinical factors as 
being predictive of recidivism
Skepticism about the value of any actuarial tool
Need to differentiate between serious and 
less serious offending
Inability of FoVOx to predict serious, as 
opposed to any, violent recidivism
Discharge due to factors other than risk 
reduction
Discharge was dictated by factors other than a 
reduction in risk.
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year also lowers risk scores; patients with a longer inpatient stay are 
more likely to be in receipt of statutory supervision after discharge.
Overall, FoVOx scores were thought to be accurate in around 
two-thirds of the cases and, for some patients, clinicians revised 
their view of the risk of future violent re-offending to a higher 
level after being informed of the FoVOx scores, suggesting that 
probability-based FoVOx scores could assist clinical decision-
making. Clinicians were more likely to underestimate risk compared 
to FoVOx scores. Reasons identified included FoVOx emphasizing 
risk factors underweighted by clinicians. Understandably, clinicians 
are most likely to focus on clinical factors which can be addressed, 
such as response to medical treatment, engagement in psychological 
therapy, and abstinence from substances abuse in the supported 
environment of hospital. Being informed of FoVOx scores thus 
may enable clinicians to rebalance the relative importance of 
these hospital-based clinical factors against static ones that are 
independently predictive of violent recidivism. Thus, using FoVOx 
routinely would prompt clinicians to keep these factors in mind, 
suggesting that FoVOx could be useful as an adjunct to clinical 
decision-making. However, local external validation is required 
to know the accuracy of FoVOx compared to clinician judgment. 
Without this, placing more weight on FoVOx scores would be 
unwarranted and clinical decision-making should take precedence. 
At the same time, awareness of the factors that might lead clinical 
teams to underestimate risk needs careful consideration—from 
weighting more recent factors, and structural (such as the need 
to maintain sustainable lengths of stay in secure services) and 
therapeutic factors.
One useful aspect of this feasibility work was to elicit views 
about the timing of FoVOx. As most factors are static and will not 
change during hospitalization, this provides some flexibility as to 
when it can be administered. At the point of discharge, patients 
are well-known to their clinical teams, and a more individualized 
and detailed risk formulation is likely to be available. FoVOx 
may be of more value if completed earlier in a patient’s pathway 
through the secure hospital system, possibly at the point of 
referral or gatekeeping into secure psychiatric care, or early in 
their admission. Completing the FoVOx tool at an earlier stage 
would allow for patient’s future risk to be stratified sooner, assist 
to guide their pathway through the secure hospital system and 
inform allocation of treatment resources.
One of the clinical implications of this study would be 
to integrate the FoVOx tool into patient care, for example 
by including it as part of their electronic patient healthcare 
record. Future work could compare FoVOx to other current 
risk assessment tools to compare acceptability and feasibility 
including the time taken to complete them, clinician satisfaction, 
and impact on patient care.
liMiTATiOnS
External validation was not conducted, which is a considerable 
challenge in forensic psychiatry due to patient numbers and 
event rates. If one assumes around 20% violent reoffending over 
2 years, then around 500 forensic psychiatric discharges would 
be recommended for a validation study (18). This would likely 
require a large multi-centre study across different regions and/
or nations. One limitation of the current investigation is that 
the outcome was based on clinical knowledge, and future work 
could triangulate this information with criminal records. When 
the available information was incomplete to complete FoVOx 
scoring, and a range of risk generated, we chose the higher value. 
An alternative would be to give an average value to missing 
variables to avoid potential over-estimation of risk.
A high proportion of cases (66%) reviewed were assigned to 
the medium risk category. If the majority of the patients are all 
assigned to the same risk class, this may reduce the clinical utility 
of the tool. Three of eleven clinicians felt that the low/medium/
high categorization was unnecessary. In future research, solely 
using the probability score of reoffending can be examined.
Another limitation is that there may have been a positive bias 
to the qualitative data as the tool was developed by researchers 
locally, including one of the interview team. The study was also 
limited to forensic psychiatrists, and the views of other clinicians 
are necessary in further work.
Overall, the clinician views on FoVOx were consistently 
positive in many respects from informing decision-making to 
assisting risk communication. The novel features of FoVOx, 
including its brevity, online platform, and ease of use suggest 
that it can improve the risk assessment process in individuals 
detained in forensic psychiatric hospital.
DATA AVAilABiliTY STATeMenT
Anonymized completed interview questionnaires and Service 
Evaluation proposal are available on request.
AUThOR COnTRiBUTiOnS
SF, RC, and AL designed the study. AL developed the standardized 
tool (Appendix 1). AL and OP completed FoVOx scoring of 
patients. RC, AL, and OP conducted clinician interviews. RC and 
OC completed thematic analysis. SF, RC, OP, SM, and AL wrote 
the paper.
FUnDing
SF is funded by the Wellcome Trust.
ACKnOWleDgMenTS
The authors would like to thank Dr Sukh Lally, Dr Susan Hardy, 
Dr Hasanen Al-Taiar, Dr Vivek Khosla, Dr Rami El-Shirbiny, Dr 
Julia Cartwright, Dr Pankaj Agarwal, Dr Srinivasan Thirumalai, 
and Dr Vijay Durge for participating in the interviews.
SUPPleMenTARY MATeRiAl
The Supplementary Material for this article can be found online at: 
https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00901/
full#supplementary-material
Frontiers in Psychiatry | www.frontiersin.org December 2019 | Volume 10 | Article 901
FoVOx Feasibility StudyCornish et al.
8
ReFeRenCeS
 1. Coid D, Hickey N, Kahtan N, Zhang T, Yang M. Patients discharged from 
medium secure forensic psychiatry services: reconvictions and risk factors. 
Br J Psychiatry (2007) 190:223–9. doi: 10.1192/bjp.bp.105.018788
 2. Fazel S, Wolf A, Fiminska Z, Larsson H. Mortality, rehospitalisation and 
violent crime in forensic psychiatric patients discharged from hospital: rates 
and risk factors. PLoS One (2016) 11(5):e0155906. doi: 10.1371/journal.
pone.0155906
 3. Khiroya R, Weaver T, Maden T. Use and perceived utility of structured 
violence risk assessments in English medium secure forensic units. 
Psychiatrist (2009) 33:129–2. doi: 10.1192/pb.bp.108.019810
 4. NHS England. (2013). NHS standard contract for medium and low secure 
mental health services (Adults). NHS England, London (https://www.
england.nhs.uk/wp-content/uploads/2013/06/c03-med-low-sec-mh.
pdf).
 5. Fazel S. “The scientific validity of current approaches to violence and 
criminal risk assessment” in Predictive sentencing: normative and empirical 
perspectives.  eds. de Keijser, Roberts, Ryberg. London: Hart. (2019): 197–
212. doi: 10.5040/9781509921447.ch-011
 6. Viljoen JL, McLachlan K, Vincent GM. Assessing violence risk and 
psychopathy in juvenile and adult offenders: a survey of clinical practices. 
Assessment (2010) 17(3):377–5. doi: 10.1177/1073191109359587
 7. Jeandarme I, Pouls C, De Laender J, Oei T, Bogaerts S. Field validity of the 
HCR-20 in forensic medium security units in Flanders. Psychol Crime Law 
(2017) 23:4:305–2. doi: 10.1080/1068316X.2016.1258467
 8. Singh JP, Grann M, Fazel S. Authorship bias in violence risk assessment? 
A systematic review and meta-analysis. PLoS One (2013) 8:e72484. doi: 
10.1371/journal.pone.0072484
 9. Singh JP, Desmarais SL, Hurducas C, Arbach-Lucioni K, Condemarin C, 
Dean K. International perspectives on the practical application of violence 
risk assessment: a global survey of 44 countries. Int J Forensic Ment Health 
(2014) 13:193–6. doi: 10.1080/14999013.2014.922141
 10. Fazel S, Chang Z, Fanshawe T, Langstrom N, Lichtenstein P, Larsson H, et al. 
Prediction of violent reoffending on release from prison: derivation and 
external validation of a scalable tool. Lancet Psychiatry (2016) 3(6):535–43 
535–3. doi: 10.1016/S2215-0366(16)00103-6
 11. Coid J, Yang M, Ullrich S, Zhang T, Sizmur S, Farrington D, et  al. 
Most items in structured risk assessment instruments do not 
predict violence. J Forensic Psychiatry Psychol (2011) 22:1:3–21. doi: 
10.1080/14789949.2010.495990
 12. Hannah-Moffat K, Marutto P. Understanding risk in the context of the 
youth criminal justice act. Can J Criminol (2007) 49(4):465–1. doi: 10.3138/
cjccj.49.4.465
 13. Fazel S, Wolf A, Larsson H, Lichtenstein P, Mallett S, Fanshawe T. 
Identification of low risk of violent crime in severe mental illness with a 
clinical prediction tool (Oxford Mental Illness and Violence tool [OxMIV]): 
a derivation and validation study. Lancet Psychiatry (2017), 4:461–8. doi: 
10.1016/S2215-0366(17)30109-8
 14. Wolf A, Fanshawe TR, Sariaslan A, Cornish R, Larsson H, Fazel S. Prediction 
of violent crime on discharge from secure psychiatric hospitals: a clinical 
prediction rule (FoVOx). Eur Psychiatry (2018) 47:88–93. doi: 10.1016/j.
eurpsy.2017.07.011
 15. Fazel S, Singh JP, Doll H, Grann M. Use of risk assessment instruments to 
predict violence and antisocial behaviour in 73 samples involving 24827 
people: systematic review and meta-analysis. BMJ (2012) 345:e4692. doi: 
10.1136/bmj.e4692
 16. Kappen T, Klei W, van Wolfswinkel L, Kalkman C, Vergouwe Y, Moons K. 
Evaluating the impact of prediction models: lessons learned, challenges, 
and recommendations. Diagn Prognost Res (2018) 2:11. doi: 10.1186/
s41512-018-0033-6
 17. Dhejne C, Lichtenstein P, Boman M, Johansson A, Langstrom N, Landen M. 
Long-term follow-up of transsexual persons undergoing sex reassignment 
surgery: cohort study in Sweden. PLoS One (2011) 6(2):e16885. doi: 10.1371/
journal.pone.0016885
 18. Vergouwe Y, Steyerberg E, Eijkemans M, Habbema J. Substantial effective 
sample sizes were required for external validation studies of predictive 
logistic regression models. J Clin Epidemiol (2005) 58(5):475–83. doi: 
10.1016/j.jclinepi.2004.06.017
Conflict of Interest: SF and RC are authors on the original FoVOx paper. 
The authors declare that the research was conducted in the absence of any 
commercial or financial relationships that could be construed as a potential 
conflict of interest.
Copyright © 2019 Cornish, Lewis, Parry, Ciobanasu, Mallett and Fazel. This is an open-
access article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) and the copyright owner(s) are credited and that the original 
publication in this journal is cited, in accordance with accepted academic practice. No 
use, distribution or reproduction is permitted which does not comply with these terms.
December 2019 | Volume 10 | Article 901Frontiers in Psychiatry | www.frontiersin.org
